Director, HCP Non-personal Promotion Marketing at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Track record of successful pharmaceutical/biotech marketing, with launch experience

Responsibilities

Develop the NPP omnichannel (POA) in partnership with HCP promotional team with a focus on balancing the needs of the broader HIV treatment portfolio
Develop and oversee execution of a comprehensive non-personal promotional strategy to support a new product launch in HIV treatment
Partner with global and internal stakeholders to shape the execution of innovative omnichannel and content creation capabilities that will propel HIV treatment for non-personal business objectives
Provide subject matter expertise to guide and shape the short- and long-term integration of novel technologies/capabilities that individualize customer strategy and promotional execution
Partner with analytics and agency partners to continually evaluate NPP performance insights and optimize tactical execution
Develops and leads key elements of the promotional brand strategy aligned to the brand campaign with a focus on campaign integration within a portfolio of HIV treatment products
Drives execution through the management and partnership with external agencies, internal cross-functional partners, and field sales
Implements product promotional communication strategy for HCP promotions ensuring alignment with the overall brand strategy
Gains approval for marketing materials through internal review process through Promotional Review Committee (PRC)
Works cross-functionally with Digital Strategy & Operations, Marketing Analytics, Market Research, Legal, Regulatory, Medical and other key internal stakeholders
Analyzes complex brand opportunities and provides logical recommendations; leads any required action planning
Ensures that all marketing activities are in compliance with regulatory and legal requirements
Manages the non-personal promotion marketing budget and project timelines

Skills

HCP Marketing

Non-personal Promotion

Digital Campaigns

Omnichannel Marketing

HCP Segmentation

Product Launch

HIV Therapy

Marketing Strategy

Promotional Effectiveness

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free